Edward Rayner appointed as Non-Executive Director News Edward Rayner appointed as Non-Executive Director
Dr. Graeme Daniels appointed as Vice President of Sales and Marketing News Dr. Graeme Daniels appointed as Vice President of Sales and Marketing
Cyto-Mine® selected by FairJourney Biologics to advance cell line development workflows News Cyto-Mine® selected by FairJourney Biologics to advance cell line development workflows
Cyto-Mine® capabilities expanded to meet cGMP requirements for drug manufacture workflows News Cyto-Mine® capabilities expanded to meet cGMP requirements for drug manufacture workflows
Biosyntia chooses Pico-Mine® platform to accelerate synthetic biology and metabolic workflows News Biosyntia chooses Pico-Mine® platform to accelerate synthetic biology and metabolic workflows
Brand identity update aligns ambitious, global commercial growth strategy News Brand identity update aligns ambitious, global commercial growth strategy
3DSecret program begins to investigate mechanisms of metastasis in cancer News 3DSecret program begins to investigate mechanisms of metastasis in cancer
Richard Hammond appointed as Chief Technical Officer News Richard Hammond appointed as Chief Technical Officer
New laboratory facilities opened at Granta Park in Cambridge, UK supports growth News New laboratory facilities opened at Granta Park in Cambridge, UK supports growth
